Gastric Inhibitory Polypeptide (6-30) amide (human) is a central fragment of human GIP with C-terminal amidation for enhanced stability. Removal of the first residues focuses analysis on the core receptor-binding region. Researchers employ it to dissect structure-activity relationships and truncate-derived activity. Its defined sequence aids mapping of critical contact sites.
CAT No: G02002
1. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
4. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
5. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More